FinThrive, the healthcare software company backed by private equity firm Clearlake Capital, just hit a speed bump.
The company's second-quarter earnings fell 17% from a year earlier, and its revenue slipped to $100 million from $105 million. That left adjusted EBITDA - a common measure of profit that strips out one-time costs - at $40 million, down from $48 million in the same period last year.
To shore up its cash position, FinThrive borrowed $150 million from its credit facility. The move comes after the company refinanced its debt less than two years ago and told investors it had used that same line of credit.
It is a reminder that even companies backed by big private equity names can hit rough patches. The question is what happens next.
Adjusted EBITDA is not just a number on a spreadsheet. It is the cash a company has left after paying for its basic operations, which is why investors watch it so closely. A 17% drop means FinThrive has less room to absorb surprises.
When a company hits a rough patch, grab the free Always Be Buying E-Book for a steadier way to invest
Revenue also dipped to $100 million versus $105 million a year ago. New business was softer too, with bookings - the value of new contracts signed - coming in at $12 million, down from $15 million.
None of these fatal on their own. But together, they suggest a company that is growing slower than it used to and perhaps growing at all.
The broader market is watching too. Billions of dollars in loans from private-equity software buyouts earlier this decade are coming due, and investors have been winning favorable terms to extend maturities. If FinThrive stumbles, it could set a template for how those negotiations go.
FinThrive's debt load adds to the pressure. The company has about $1 billion in debt due in 2028, and its first-lien term loan is trading at 55-60 cents on the dollar, a sign that lenders already see meaningful risk in its capital structure.
If you own FinThrive's bonds or loans, this is a company to watch closely. If you do not, the company's struggles are still a useful reminder: even well-funded software companies can hit a rough patch.
The good news is that revenue and adjusted EBITDA both rose from the first quarter. That suggests the worst may be behind the company, even if the road ahead is not exactly smooth.
For the rest of us, the real takeaway is simpler. When a company draws on its credit line and reports falling profits, it is worth asking why. The answer is not always a disaster, but it is rarely nothing.
Given strong companies can stumble, so claim the free Always Be Buying E-Book and keep building your wealth